Recursion Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $35,538 | $5,175 | $19,103 | $14,745 |
Gross Profit | 8,662 | -24,418 | -1,058 | -7,084 |
EBITDA | -88,624 | -141,207 | -147,568 | -182,806 |
EBIT | -108,102 | -162,250 | -171,417 | -202,137 |
Net Income | -108,124 | -162,253 | -171,897 | -202,487 |
Net Change In Cash | 35,538 | 5,175 | 19,103 | 14,745 |
Free Cash Flow | -47,317 | -117,603 | -79,568 | -133,789 |
Cash | 743,294 | 659,836 | 528,216 | 500,453 |
Basic Shares | 526,719 | 446,988 | 417,361 | 402,772 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $74,681 | $58,839 | $43,876 | $39,681 |
Gross Profit | -46,273 | 13,601 | 1,289 | -8,594 |
EBITDA | -559,384 | -426,722 | -307,629 | -233,971 |
EBIT | -643,085 | -463,216 | -332,031 | -245,727 |
Net Income | -644,759 | -463,661 | -328,066 | -239,421 |
Net Change In Cash | 74,681 | 58,839 | 43,876 | 39,681 |
Free Cash Flow | -378,277 | -372,869 | -300,332 | -120,883 |
Cash | 743,294 | 594,350 | 391,565 | 549,912 |
Basic Shares | 447,446 | 274,207 | 207,853 | 175,537 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.21 |
2025-09-30 | -$0.36 |
2025-06-30 | -$0.41 |
